What is Emergent Biosolutions, Inc.'s Market Cap?

Emergent Biosolutions, Inc.'s Market Cap is $308.2M, based on as-reported figures from SEC (XBRL) filings.

What is Emergent Biosolutions, Inc.'s Enterprise Value?

Emergent Biosolutions, Inc.'s Enterprise Value is $750.3M, based on as-reported figures from SEC (XBRL) filings.

What is Emergent Biosolutions, Inc.'s Price / Sales?

Emergent Biosolutions, Inc.'s Price / Sales is 0.4×, based on as-reported figures from SEC (XBRL) filings.

What is Emergent Biosolutions, Inc.'s EV / Revenue?

Emergent Biosolutions, Inc.'s EV / Revenue is 1.0×, based on as-reported figures from SEC (XBRL) filings.

What is Emergent Biosolutions, Inc.'s EV / EBITDA?

Emergent Biosolutions, Inc.'s EV / EBITDA is 26.4×, based on as-reported figures from SEC (XBRL) filings.

What is Emergent Biosolutions, Inc.'s Revenue (TTM)?

Emergent Biosolutions, Inc.'s Revenue (TTM) is $770.2M, based on as-reported figures from SEC (XBRL) filings.

What is Emergent Biosolutions, Inc.'s Net Income (TTM)?

Emergent Biosolutions, Inc.'s Net Income (TTM) is -$176.8M, based on as-reported figures from SEC (XBRL) filings.

What is Emergent Biosolutions, Inc.'s EBITDA?

Emergent Biosolutions, Inc.'s EBITDA is $28.4M, based on as-reported figures from SEC (XBRL) filings.

What is Emergent Biosolutions, Inc.'s Diluted EPS (TTM)?

Emergent Biosolutions, Inc.'s Diluted EPS (TTM) is -3.45, based on as-reported figures from SEC (XBRL) filings.

What is Emergent Biosolutions, Inc.'s EBITDA Margin?

Emergent Biosolutions, Inc.'s EBITDA Margin is 3.7%, based on as-reported figures from SEC (XBRL) filings.

Emergent Biosolutions, Inc. (EBS) Financial Statements

Emergent Biosolutions, Inc.

SIC 2834 · PHARMACEUTICAL PREPARATIONS

FIGI BBG001SP1G40

XNYS · usd

6.01▲ 0.01 (0.17%)

As of 2026-09-09

Valuation

Market Cap

Enterprise Value

Trailing P/E—

Price / Sales

EV / Revenue

EV / EBITDA

Financial Highlights

Revenue (TTM)

Net Income (TTM)

EBITDA

Diluted EPS (TTM)

EBITDA Margin

Net Debt

Trading Information

Previous Close6.00

Day's Range5.96 – 6.15

52-Week Range4.36 – 14.06

Volume701.2K

Avg Volume1.3M

Share Statistics

Shares Outstanding

Employees900

ExchangeXNYS

Listed2006-11-15

Share count as of July 30, 2026

ViewDetail

Period

Loading Income Statement…

Key questions about Emergent Biosolutions, Inc. (EBS)

What is Emergent Biosolutions, Inc.'s Market Cap?: Emergent Biosolutions, Inc.'s Market Cap is $308.2M, based on as-reported figures from SEC (XBRL) filings.
What is Emergent Biosolutions, Inc.'s Enterprise Value?: Emergent Biosolutions, Inc.'s Enterprise Value is $750.3M, based on as-reported figures from SEC (XBRL) filings.
What is Emergent Biosolutions, Inc.'s Price / Sales?: Emergent Biosolutions, Inc.'s Price / Sales is 0.4×, based on as-reported figures from SEC (XBRL) filings.
What is Emergent Biosolutions, Inc.'s EV / Revenue?: Emergent Biosolutions, Inc.'s EV / Revenue is 1.0×, based on as-reported figures from SEC (XBRL) filings.
What is Emergent Biosolutions, Inc.'s EV / EBITDA?: Emergent Biosolutions, Inc.'s EV / EBITDA is 26.4×, based on as-reported figures from SEC (XBRL) filings.
What is Emergent Biosolutions, Inc.'s Revenue (TTM)?: Emergent Biosolutions, Inc.'s Revenue (TTM) is $770.2M, based on as-reported figures from SEC (XBRL) filings.
What is Emergent Biosolutions, Inc.'s Net Income (TTM)?: Emergent Biosolutions, Inc.'s Net Income (TTM) is -$176.8M, based on as-reported figures from SEC (XBRL) filings.
What is Emergent Biosolutions, Inc.'s EBITDA?: Emergent Biosolutions, Inc.'s EBITDA is $28.4M, based on as-reported figures from SEC (XBRL) filings.
What is Emergent Biosolutions, Inc.'s Diluted EPS (TTM)?: Emergent Biosolutions, Inc.'s Diluted EPS (TTM) is -3.45, based on as-reported figures from SEC (XBRL) filings.
What is Emergent Biosolutions, Inc.'s EBITDA Margin?: Emergent Biosolutions, Inc.'s EBITDA Margin is 3.7%, based on as-reported figures from SEC (XBRL) filings.